These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6978672)

  • 1. Multiple sclerosis: heterology among early T cells and Tg cells.
    Traugott U; Scheinberg LC; Raine CS
    Ann Neurol; 1982 Feb; 11(2):182-6. PubMed ID: 6978672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution.
    Laplaud DA; Ruiz C; Wiertlewski S; Brouard S; Berthelot L; Guillet M; Melchior B; Degauque N; Edan G; Brachet P; Damier P; Soulillou JP
    Brain; 2004 May; 127(Pt 5):981-95. PubMed ID: 14985265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Mirabella M; Tonali PA; Batocchi AP
    J Neuroimmunol; 2008 Dec; 205(1-2):126-34. PubMed ID: 18926576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective immunoregulation in multiple sclerosis.
    Goust JM; Hoffman PM; Pryjma J; Hogan EL; Fudenberg HH
    Ann Neurol; 1980 Nov; 8(5):526-33. PubMed ID: 7436394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The regulatory role of natural killer cells in multiple sclerosis.
    Takahashi K; Aranami T; Endoh M; Miyake S; Yamamura T
    Brain; 2004 Sep; 127(Pt 9):1917-27. PubMed ID: 15229129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
    García-Merino A; Barcenilla H; Díaz D; Monserrat J; Prieto A; Alvarez-Mon M;
    Clin Immunol; 2009 Aug; 132(2):195-202. PubMed ID: 19443275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 T cell activation and disease activity at onset of multiple sclerosis.
    Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F
    J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral blood gamma delta T cells in multiple sclerosis].
    Ejima M; Ota K; Tanaka H; Maruyama S
    Rinsho Shinkeigaku; 1993 Nov; 33(11):1131-4. PubMed ID: 8124869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.
    Svenningsson A; Hansson GK; Andersen O; Andersson R; Patarroyo M; Stemme S
    Ann Neurol; 1993 Aug; 34(2):155-61. PubMed ID: 8338339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: T-cell receptor expression in distinct brain regions.
    Junker A; Ivanidze J; Malotka J; Eiglmeier I; Lassmann H; Wekerle H; Meinl E; Hohlfeld R; Dornmair K
    Brain; 2007 Nov; 130(Pt 11):2789-99. PubMed ID: 17890278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients.
    Strunk T; Bubel S; Mascher B; Schlenke P; Kirchner H; Wandinger KP
    Ann Neurol; 2000 Feb; 47(2):269-73. PubMed ID: 10665504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: limited diversity of the V delta 2-J delta 3 T-cell receptor in chronic active lesions.
    Battistini L; Selmaj K; Kowal C; Ohmen J; Modlin RL; Raine CS; Brosnan CF
    Ann Neurol; 1995 Feb; 37(2):198-203. PubMed ID: 7847861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Memory T cell subsets in peripheral blood of patients with multiple sclerosis].
    Liu GZ; Gao XG
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2750-2. PubMed ID: 18167264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte reconstitution following rigorously T-cell-depleted versus unmodified autologous stem cell transplants.
    Te Boekhorst PA; Lamers CH; Schipperus MR; Hintzen RQ; van der Holt B; Cornelissen JJ; Löwenberg B; Gratama JW
    Bone Marrow Transplant; 2006 Apr; 37(8):763-72. PubMed ID: 16518423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The level of soluble forms of interleukin-2 receptor and adhesive molecules ICAM-1 and VCAM-1 in platelets of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 1999 Jan; 6(31):23-6. PubMed ID: 10344149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.